Epidural Steroid Injections for the Management of Spinal Malignancy-Related Pain: A Pragmatic Review and Retrospective Study.

BACKGROUND: Spinal malignancy-related pain results from tumor, fracture, instability, inflammation, and/or nerve root/spinal cord compression. Systemic corticosteroids are commonly used but have many undesirable adverse effects that impact quality of life and continuation of cancer treatments. Epidural steroid injections (ESIs) may be a viable alternative pain treatment. OBJECTIVES: This study starts with a pragmatic review on the efficacy of ESIs to treat spinal malignancy-related pain. Given the limited evidence, we supplement the study with a single-center, retrospective review. METHODS: A pragmatic review using PRISMA guidelines was conducted in MEDLINE, EMBASE, SCOPUS, and Cochrane Review. Then, a retrospective chart review was performed. RESULTS: A pragmatic review yielded 10 patients who underwent ESI for spinal malignancy-related pain. Three patients had "excellent" relief (≥ 50% relief), who all received thoracic injections. This amounted to level IV evidence and an inconclusive recommendation (Grade C) as per Wright's criteria. In our retrospective review, all thoracic cases achieved at least "moderate" pain improvement (30% to 49% relief). 55.6% had "excellent" relief. Lumbosacral injections resulted in 86.0% with at least "moderate" relief and 69.8% with "excellent" relief. Caudal injections were less likely to benefit than lumbosacral injections (P = 0.02). The transforaminal approach resulted in the best relief. There were no adverse events. CONCLUSIONS: There is inconclusive evidence to use ESIs to treat spinal malignancy-related pain in the current literature. Our retrospective review provides level III evidence for our conclusion that ESIs are safe and efficacious to treat spinal malignancy-related pain. Thoracic/lumbosacral injections led to significantly better pain relief compared with caudal injections.

Interventional Pain Treatments in the Management of Oncologic Patients With Thoracic Spinal Tumor-Related Pain: A Case Series.

BACKGROUND: Advanced tumors of the thoracic spine are difficult to treat and can lead to complex pain syndromes. Following conventional oncologic treatments, pharmacologic therapy may be insufficient to manage pain. Minimally invasive interventional procedures offer alternatives to treat malignant thoracic spinal pain. METHODS: Thirteen patients with metastatic disease and poorly controlled thoracic axial and/or radicular pain were identified via a retrospective chart review. Patients were either treated with radiation, surgery, chemotherapy, or a combination of these. Then, the patients were organized into groups based on their diagnoses, anatomical disease locations, symptoms, prior treatments, and interventional pain procedures offered. RESULTS: All cases of intercostal nerve, costotransverse junction, erector spinae plane, and paravertebral blocks resulted in pain relief without any reported complications. A patient who received a thoracic epidural injection had a complete resolution of pain when combined with radiation therapy 2 weeks after the injection. One patient who underwent repeat thoracic epidural injections eventually had an intrathecal pump placement, resulting in reduced opioid usage. Finally, 1 patient who received a thoracic medial branch block with a relief of thoracic axial pain reported greater pain relief with a medial branch nerve cryoablation. CONCLUSION: We propose a treatment algorithm to manage patients with thoracic spinal tumor-related pain. Interventional thoracic axial procedures may be safe and efficacious pain treatments for patients with cancer.

Myofascial Pelvic Pain and Related Disorders.

Myofascial pelvic pain refers to pain in the pelvic floor muscles, the pelvic floor connective tissue, and the surrounding fascia. The cause is often multifactorial and requires treatment that encompasses multiple modalities. This type of pain is often associated with other abdominopelvic disorders, so providers in these specialties need to be aware of these connections. A comprehensive musculoskeletal examination, including evaluation of the pelvic floor muscles, and history are key to diagnosing myofascial pelvic pain. Treatments include physical therapy, muscle relaxers, oral neuromodulators, cognitive-behavioral therapy, and pelvic floor muscle injections.

Successful Treatment of Gluteal Pain from Obturator Internus Tendinitis and Bursitis with Ultrasound-Guided Injection.

This case report describes what the authors believe is the first case of a patient with obturator internus tendinitis and bursitis successfully treated with a corticosteroid injection using a trans-tendinous lateral to medial approach. The patient presented with right gluteal pain not relieved by physical therapy or right hip and ischial bursa corticosteroid injections. Pelvic and lumbar spine MRIs and EMG/NCS findings were unremarkable. Physical examination demonstrated tenderness to palpation at the right middle lower gluteal region. Ultrasound imaging with sonopalpation identified the maximal local tender point as the right obturator internus muscle and/or its underlying bursa. A 22-gauge 3.5-inch needle was inserted in-plane to the transducer and longitudinal to the obturator internus from a lateral to medial direction, an approach previously described in cadavers. The obturator internus tendon sheath and bursa were injected with 2.5 ml of 0.5% lidocaine combined with 10 mg of triamcinolone. The patient reported immediate complete relief of pain with continued relief at 2 and 6 months post-injection. This case report demonstrates an injection of the obturator internus tendon sheath and bursa using a trans-tendinous approach, which may be successful for treatment of patients presenting with persistent gluteal pain from obturator internus tendinitis and bursitis.

Optimal needle entry angle for cervical transforaminal epidural injections.

BACKGROUND: Cervical epidural steroid injections can be performed through either interlaminar or transforaminal approaches, although the interlaminar approach is more frequently used, for cervical radicular pain as a result of cervical disc herniation or spinal stenosis. Cervical selective nerve root block (CSNRB) is an injection that uses a similar approach to that of cervical transforaminal epidural steroid injection (CTFESI) but CSNRB is mainly used for diagnostic injection, often with local anesthetic only. OBJECTIVE: The aim of this study was to investigate an optimal needle entry angle for cervical transforaminal epidural steroid injection (CTFESI) or cervical selective nerve root block (CSNRB) using the fluoroscopically guided anterior oblique approach. The angle for optimal entry into the neuroforamen was measured at various vertebral levels using cross-sectional cervical spine computed tomography (CT) scans. STUDY DESIGN: Retrospective case series analysis. METHODS: From March 2009 to July 2012, consecutive patients with presumed discogenic neck pain underwent cervical post discography CT scans. The axial images of these CT scans were used to measure the optimal angle for needle entry into the neuroforamen. The angles were taken bilaterally at levels of C3-4, C4-5, C5-6, C6-7, and C7-T1. The average angle between the patient's left and right side was calculated. A total of 190 patients were analyzed, including 73 men and 117 women, with ages ranging from 21 to 78 years old. RESULTS: In both men and women, the mean optimal angle (in degrees) with standard deviation measured in the 190 patients at C3-4, C4-5, C5-6, C6-7, and C7-T1 were 48 ± 4, 49 ± 4, 49 ± 4, 49 ± 5, 48 ± 6, respectively. The 95% confidence interval for the true value of the parameter is within 39.84 to 57.56 degrees. LIMITATIONS: The data for the optimal needle entry angle for CTFESI has yet to be tested or confirmed in clinical studies. CONCLUSION: This is the first study investigating the optimal needle entry angle for performing CTFESIs or CSNRB. Based on a patient population of 190, the optimal entry angle using the anterior oblique approach appears to be between the range of 33 to 68 degrees with an average of slightly less than 50 degrees. Further research with angle of needle entry and/or initial fluoroscopic alignment of approximately 50 degrees in CTFESI or CSNRB is warranted to confirm the usefulness of these findings.